MSKCC In Press Publications

• At-RS31 orchestrates hierarchical cross-regulation of splicing factors and integrates alternative splicing with TOR-ABA pathways
  2025; New Phytologist; Koster T. | Venhuizen P. | Lewinski M. | Petrillo E. | Marquez Y. | Fuchs A. | Ray D. | Nimeth B.A. | ...
• A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-α biologic therapy
  2025; Med; Kennedy J.C. | Vargas S.O. | Fishman M.P. | Alesi N. | Baek S.-H. | Khabibillin D. | Platt C.D. | Garcia-de-Alba C. | ...
• Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
  2025; Cell; Kim W.J. | Crosse E.I. | De Neef E. | Etxeberria I. | Sabio E.Y. | Wang E. | Bewersdorf J.P. | Lin K.-T. | ...
• The grand biological universe: A comprehensive geometric construction of genome space
  2025; Innovation; Yu H. | Sun N. | Ren R. | Zhou T. | Guan M. | Zhao L. | Yau S.S.-T.
• SHEA/APIC/IDSA/PIDS multisociety position paper: Raising the bar: necessary resources and structure for effective healthcare facility infection prevention and control programs
  2025; Infection Control and Hospital Epidemiology; Talbot T.R. | Baliga C. | Crapanzano-Sigafoos R. | ...
• A plain language summary of the molecular changes in the tumors of people with BRAF V600E–mutant colorectal cancer in the BEACON study
  2025; Future Oncology; Kopetz S. | Murphy D.A. | Pu J. | Ciardiello F. | Desai J. | Van Cutsem E. | Wasan H.S. | Yoshino T. | ...
• Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01)
  2025; JCO Oncology Practice; Atkinson T.M. | Mazumdar M. | Van Hyfte G. | Lee J.Y. | Li Y. | Lynch K.A. | Webb A. | ...
• Pediatric DTC Genetic Testing for Adult-Onset Inherited Cancer Risk: The Perspectives of High-Risk Parents
  2025; Public Health Genomics; Kilbride M.K. | Peshkin B.N. | Hamilton J.G. | Brower J. | Ovadia H. | Friedman Ross L. | ...
• Clinical Bioinformatician Body of Knowledge—Clinical Laboratory Regulation and Data Security Core: A Report of the Association for Molecular Pathology
  2025; Journal of Molecular Diagnostics; Schmidt R.J. | Furtado L.V. | Fussell A.M. | Jordan D. | Lebo M. | Syed A. | ...
• Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
  2025; Molecular Oncology; Swanton C. | Madison R.W. | Tambaoan C.F.B. | Meric-Bernstam F. | Sweeney C.J. | Kurzrock R. | ...
• Access all results for your search in Scopus

Content provided by Scopus

Last updated: 2025-06-10 05:05:14 -0400